NPPA fixes and revises ceiling prices of 15 scheduled formulations, details
New Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA) has fixed and revised the ceiling price of 15 scheduled formulations.
The list includes Azithromycin, Clomiphene citrate, Dexamethasone, Efavirenz, Fluconazole, Fluoxetine, Gentamicin, Japanese encephalitis vaccine, Paracetamol, Povidone iodine, and others.
Scheduled formulation means any formulation, included in the First Schedule whether referred to by generic versions or brand names (mainly products covered under the National List of Essential Medicines are Scheduled Formulation). In other words, all medicines that are covered in the National List of Essential Medicine, which are notified in Schedule 1, by the Govt. are scheduled formulation.
Sl. No. | Name of the Scheduled Formulation | Dosage form and strength | Unit | Ceiling Price (Rs.) |
(1) | (2) | (3) | (4) | (5) |
1 | Capsule 500mg | 1 Capsule | 19.03 | |
2 | Clomiphene citrate | Capsule 50mg | 1 Capsule | 27.37 |
3 | Clomiphene citrate | Capsule 100 mg | 1 Capsule | 51.14 |
4 | Dexamethasone | Injection 4mg/mL (2 ML) | 1 ML | 5.09 |
5 | Efavirenz | Capsule 200 mg | 1 Capsule | 21.98 |
6 | Fluconazole | Capsule 100mg | 1 Capsule | 21.40 |
7 | Fluoxetine | Tablet 10 mg | 1 Tablet | 2.78 |
8 | Fluoxetine | Tablet 40 mg | 1 Tablet | 5.56 |
9 | Fluoxetine | Tablet 60 mg | 1 Tablet | 8.25 |
10 | Fluoxetine | Tablet 20 mg | 1 Tablet | 4.15 |
11 | Gentamicin | Injection 40mg/mL (2ml) | 1 ML | 4.85 |
12 | Japanese encephalitis vaccine | As licensed (4mcg to 6 mcg) | 1 Vial | 677.13 |
13 | Japanese encephalitis vaccine | As licensed (upto 3 mcg) | 1 Vial | 518.63 |
14 | Paracetamol | Injection 150mg/mL (2ML) | 1 ML | 3.97 |
15 | Povidone iodine | Solution 4% | 1 ML | 1.57 |
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.